BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 19737580)

  • 1. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
    Kincheski GC; Carobrez AP
    Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
    de Paula Soares V; Zangrossi H
    Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
    Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
    Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fear state induced by ethanol withdrawal may be due to the sensitization of the neural substrates of aversion in the dPAG.
    Cabral A; Isoardi N; Salum C; Macedo CE; Nobre MJ; Molina VA; Brandão ML
    Exp Neurol; 2006 Jul; 200(1):200-8. PubMed ID: 16624300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dorsal periaqueductal and basolateral amygdala are necessary for the expression of conditioned place avoidance induced by semicarbazide stimulation of the dorsal periaqueductal region.
    Zanoveli JM; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1715-21. PubMed ID: 18687375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
    Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
    Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
    Moraes CL; Bertoglio LJ; Carobrez AP
    Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
    Borelli KG; Brandão ML
    Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats.
    Santos P; Bittencourt AS; Schenberg LC; Carobrez AP
    Neuropharmacology; 2006 Aug; 51(2):203-12. PubMed ID: 16697017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of NK1 receptors of the amygdala on the processing of different types of fear.
    Carvalho MC; Santos JM; Bassi GS; Brandão ML
    Neurobiol Learn Mem; 2013 May; 102():20-7. PubMed ID: 23567110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick tests.
    Bassi GS; Nobre MJ; de Araújo JE; Brandão ML
    Neuropeptides; 2007 Dec; 41(6):365-74. PubMed ID: 17981325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
    Carvalho MC; Santos JM; Brandão ML
    Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral sensitization induced by dorsal periaqueductal gray electrical stimulation is counteracted by NK1 receptor antagonism in the ventral hippocampus and central nucleus of the amygdala.
    Carvalho MC; Veloni AC; Genaro K; Brandão ML
    Neurobiol Learn Mem; 2018 Feb; 148():60-68. PubMed ID: 29519453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-allylglycine dissociates the neural substrates of fear in the periaqueductal gray of rats.
    Cunha JM; Zanoveli JM; Ledvinka-Filho E; Brandão ML
    Brain Res Bull; 2010 Mar; 81(4-5):416-23. PubMed ID: 19800953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray.
    Yamashita PS; de Bortoli VC; Zangrossi H
    Neuropharmacology; 2011; 60(2-3):216-22. PubMed ID: 20850460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray.
    Broiz AC; Bassi GS; De Souza Silva MA; Brandão ML
    Neuroscience; 2012 Jan; 201():134-45. PubMed ID: 22123168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.